ArticleJournal of translational medicine2025

MCAM interacts with integrin β1 to promote EGFR-TKI resistance in lung adenocarcinoma through the JAK3 signalling pathway.

Saiqun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.